Search

Search Results

• CO015 | EVOLUTION OF ANTICOAGULANT THERAPY FOR CANCER-ASSOCIATED THROMBOSIS: THE START2 REGISTRY ONCO-VTE LONGITUDINAL STUDY M. Marchetti^1|2, T. Zollner^1|2, O.C. Cretu^1|2, A. Chistolini³, R. Pancani⁴, L. Puccetti⁵, P. Sivera⁶, W. Ageno⁷, G. Elmi⁸, V. Fregoni⁹, V. Tonelli¹⁰, E. Antonucci¹¹, D. Poli^11|12, A. Falanga^1|2, L. Barcella^1|2 | ¹Hemostasis & Thrombosis Center, Department of Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy; ²ERN EuroBloodNet; ³Hematology Unit, Department of Translational and Precision Medicine, Sapienza University of Roma, Roma, Italy; ⁴Pulmonary Unit, Hospital of Siena, University of Siena, Siena, Italy; ⁵Hemostasis and Thrombosis Unit, Hospital of Siena, University of Siena, Siena, Italy; ⁶Haematology Unit, Ordine Mauriziano Hospital, Torino, Italy; ⁷Department of Medicine, University of Padua, Padova, Italy; ⁸Department of Medicine, Maggiore Hospital, Bologna, Italy; ⁹Department of Medicine, Sondalo Hospital, Sondalo, Italy; ¹⁰Angiology Unit, Sant'Eugenio Hospital, Roma, Italy; ¹¹Arianna Anticoagulazione Foundation, Bologna, Italy; ¹²Department of Critical Care Medicine, Thrombosis Centre, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy

  Marina Marchetti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.717

  10

  PDF: 2

• CO112 | LIPOPROTEIN(a) PLASMA LEVELS AND COAGULATION BIOMARKERS: RESULTS FROM A COMPREHENSIVE LABORATORY ASSESSMENT IN AN ANGIOGRAPHICALLY-CONTROLLED CARDIOVASCULAR COHORT N. Osti¹, G. Musuraca¹, M. Spizzo², P. Pattini², G. Poli³, C. Brocco¹, C. Cemin¹, A. Madaffari¹, G. Mango², F. Presa², M. Grusse⁴, P. Van Dreden⁴, A. Anesi¹, G. Lippi³, M. Del Greco¹, A. Castagna², S. Friso², A. Ferro¹, N. Martinelli² | ¹Azienda Sanitaria Universitaria Integrata del Trentino (ASUIT), Trento, Italy; ²U.O. Medicina Interna B, Dip. Medicina, Università di Verona, Italy; ³Sez. Biochimica Clinica, Università di Verona, Italy; ⁴Dep. Clinical Research, Diagnostica Stago, Gennevilliers, France

  Nicola Osti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.814

  6

  PDF: 2

• CO048 | PREDICTORS OF FIRST THROMBOTIC EVENTS AFTER MECHANICAL VALVE REPLACEMENT FOR RHEUMATIC HEART DISEASE: A RETROSPECTIVE COHORT STUDY FROM SALAM CENTER FOR CARDIAC SURGERY (SUDAN) N. Erba^1|3, S. Abdelwahab Abdallah¹, D. Poli³, M. Langer², G. Portella², E. Giovanella¹, F. Masini¹, P. Malerba² | ¹The Salam Centre for Cardiac Surgery, Emergency NGO, Khartoum, Sudan; ²Emergency NGO Milano, Italy; ³Federazione dei Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Anti trombotiche, Italy

  Nicoletta Erba

  26-10-2026

  https://doi.org/10.4081/btvb.2026.750

  7

  PDF: 2

• CO058 | ELEVATED PLASMA LEVELS OF OMEGA-3 STEARIDONIC ACID ARE ASSOCIATED WITH DECREASED FACTOR VIII COAGULANT ACTIVITY INDEPENDENTLY OF FACTOR VIII ANTIGEN AND VON WILLEBRAND FACTOR LEVELS: PRELIMINARY RESULTS FROM AN ANGIOGRAPHICALLY-CONTROLLED CARDIOVASCULAR COHORT STUDY N. Osti¹, G. Musuraca¹, A. Castagna², M. Spizzo², P. Pattini², G. Mango², M. Baroni³, B. Lunghi³, G. Poli⁴, C. Brocco¹, C. Angheben¹, M. Grusse⁵, P. Van Dreden⁵, A. Anesi¹, G. Lippi³, M. Del Greco¹, S. Friso², A. Ferro¹, F. Bernardi³, N. Martinelli² | ¹Azienda Sanitaria Universitaria Integrata del Trentino, Trento, Italy; ²Dip. di Medicina, Università di Verona, Verona, Italy; ³Dip. di Scienze della Vita e Biotecnologie, Università di Ferrara, Ferrara, Italy; ⁴Sez. di Biochimica Clinica, Università di Verona, Verona, Italy; ⁵Clinical Research, Diagnostica STAGO, Gennevillers, France

  Nicola Osti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.760

  6

  PDF: 2

• PO143 | GENDER DIFFERENCES IN COAGULATION PROFILE IN OBSTRUCTIVE CORONARY ARTERY DISEASE: PRELIMINARY RESULTS FROM AN ANGIOGRAPHICALLY CONTROLLED COHORT STUDY N. Osti¹, G. Musuraca¹, M. Spizzo², P. Pattini², G. Mango², F. Ambrosani², G. Poli³, C. Brocco¹, C. Angheben¹, M. Donini¹, F. Presa², M. Grusse⁴, P. Van Dreden⁴, A. Anesi¹, G. Lippi³, M. Del Greco¹, A. Castagna², S. Friso², A. Ferro¹, N. Martinelli² | ¹Azienda Sanitaria Universitaria Integrata del Trentino, Trento, Italy; ²Dip. di Medicina, Università di Verona, Verona, Italy; ³Sez. di Biochimica Clinica, Università di Verona, Verona, Italy; ⁴Clinical Research, Diagnostica STAGO, Gennevillers, France

  Nicola Osti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.959

  6

  PDF: 2

• CO045 | BEYOND THE VISIBLE: LIPOPROTEIN(a) AS A SILENT DRIVER OF RETINAL VASCULAR DAMAGE L. Agrelli¹, M. Berteotti², E. Lotti², F. Crudele², D. Poli², A.M. Gori², A Rogolino², D. Prisco², R. Marcucci² | ¹Department of Internal Medicine, University of Salerno, Italy; ²Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, AOU Careggi, Firenze, Italy

  Lucia Agrelli

  26-10-2026

  https://doi.org/10.4081/btvb.2026.747

  7

  PDF: 2